{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:32:28Z","timestamp":1760243548688,"version":"build-2065373602"},"reference-count":20,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the World Health Organization (WHO) in March 2020 [...]<\/jats:p>","DOI":"10.3390\/cancers14184497","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T22:12:43Z","timestamp":1663539163000},"page":"4497","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preface of the Special Issue \u201cCOVID-19 Infection and Hematological Malignancies\u201d"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6754-0480","authenticated-orcid":false,"given":"Mingyi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Hematopathology, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Larry D.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Myeloma, Waldenstrom\u2019s, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e13868","DOI":"10.1111\/ijcp.13868","article-title":"Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments","volume":"75","author":"Boban","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_2","unstructured":"World Health Organization (2022, September 10). WHO Corona Virus (COVID-19) Dash Board. Available online: https:\/\/covid19.who.int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.molpharmaceut.0c00608","article-title":"COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies","volume":"18","author":"Salian","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00277-020-04366-y","article-title":"Hematologic disorders associated with COVID-19: A review","volume":"100","author":"Rahi","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_8","unstructured":"American Society of Hematology (2022, September 10). COVID-19 and Acute Myeloid Leukemia: Frequently Asked Questions. Available online: https:\/\/www.hematology.org\/covid-19\/covid-19-and-acute-myeloid-leukemia."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00277-020-04328-4","article-title":"COVID-19 in cancer patients: Clinical characteristics and outcome-an analysis of the LEOSS registry","volume":"100","author":"Ruthrich","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1182\/blood.2021013445","article-title":"Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients","volume":"139","author":"Liebers","year":"2022","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"U.S. Food & Drug. (2022, September 10). US FDA Pfizer-BioNTech COVID-19 Vaccine, Available online: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/comirnaty-and-pfizer-biontech-covid-19-vaccine.","DOI":"10.47287\/cen-09931-buscon1"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood.2021014124","article-title":"COVID-19 in vaccinated adult patients with hematological malignancies: Preliminary results from EPICOVIDEHA","volume":"139","author":"Pagano","year":"2022","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41571-022-00610-8","article-title":"COVID-19 vaccines in patients with cancer: Immunogenicity, efficacy and safety","volume":"19","author":"Fendler","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ccell.2021.11.006","article-title":"Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer","volume":"40","author":"Shapiro","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ccell.2021.07.012","article-title":"Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies","volume":"39","author":"Greenberger","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_17","unstructured":"American Society of Hematology (2022, September 10). COVID-19 and Multiple Myeloma. Available online: https:\/\/www.hematology.org\/covid-19\/covid-19-and-multiple-myeloma."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S2352-3026(20)30124-1","article-title":"Management of patients with multiple myeloma during the COVID-19 pandemic","volume":"7","author":"Malard","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000507690","article-title":"Multiple Myeloma in the Time of COVID-19","volume":"143","author":"Sher","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_20","unstructured":"International Myeloma Society (2022, September 10). International Myeloma Society Recommendations for the Management of Myeloma Patients during the COVID-19 Pandemic. Available online: https:\/\/cms.cws.net\/content\/beta.myelomasociety.org\/files\/IMS%20recommendations%20for%20Physicians%20Final.pdf."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/18\/4497\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:32:51Z","timestamp":1760142771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/18\/4497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":20,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["cancers14184497"],"URL":"https:\/\/doi.org\/10.3390\/cancers14184497","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}